换一批Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
第一作者：
Tomas,Kalincik
第一单位：
Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.;CORe, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
作者：
Tomas,Kalincik [1]
;
Sifat,Sharmin [1]
;
Izanne,Roos [1]
;
Mark S,Freedman [2]
;
Harold,Atkins [3]
;
Joachim,Burman [4]
;
Jennifer,Massey [5]
;
Ian,Sutton [6]
;
Barbara,Withers [7]
;
Richard,Macdonell [8]
;
Andrew,Grigg [9]
;
Øivind,Torkildsen [10]
;
Lars,Bo [10]
;
Anne Kristine,Lehmann [11]
;
Eva Kubala,Havrdova [12]
;
Eva,Krasulova [12]
;
Marek,Trnený [13]
;
Tomas,Kozak [14]
;
Anneke,van der Walt [15]
;
Helmut,Butzkueven [15]
;
Pamela,McCombe [16]
;
Olga,Skibina [17]
;
Jeannette,Lechner-Scott [18]
;
Barbara,Willekens [19]
;
Elisabetta,Cartechini [20]
;
Serkan,Ozakbas [21]
;
Raed,Alroughani [22]
;
Jens,Kuhle [23]
;
Francesco,Patti [24]
;
Pierre,Duquette [25]
;
Alessandra,Lugaresi [26]
;
Samia J,Khoury [27]
;
Mark,Slee [28]
;
Recai,Turkoglu [29]
;
Suzanne,Hodgkinson [30]
;
Nevin,John [31]
;
Davide,Maimone [32]
;
Maria Jose,Sa [33]
;
Vincent,van Pesch [34]
;
Oliver,Gerlach [35]
;
Guy,Laureys [36]
;
Liesbeth,Van Hijfte [36]
;
Rana,Karabudak [37]
;
Daniele,Spitaleri [38]
;
Tunde,Csepany [39]
;
Riadh,Gouider [40]
;
Tamara,Castillo-Triviño [41]
;
Bruce,Taylor [42]
;
Basil,Sharrack [43]
;
John A,Snowden [44]
;
MSBase Study Group Collaborators [40]
;
MSBase Study Group Authors [45]
;
Saloua,Mrabet [46]
;
Justin,Garber [47]
;
Jose Luis,Sanchez-Menoyo [48]
;
Eduardo,Aguera-Morales [49]
;
Yolanda,Blanco [50]
;
Abdullah,Al-Asmi [51]
;
Bianca,Weinstock-Guttman [52]
;
Yara,Fragoso [53]
;
Koen,de Gans ;
Allan,Kermode ;
MSBase Study Group
作者单位：
Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.;CORe, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
[1]
University of Ottawa, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
[2]
Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
[3]
Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
[4]
Department of Neurology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.;St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
[5]
Department of Neurology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.;University of Sydney, Sydney, New South Wales, Australia.
[6]
St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.;Department of Haematology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
[7]
Department of Neurology, Austin Health, Melbourne, Victoria, Australia.;University of Melbourne, Melbourne, Victoria, Australia.
[8]
University of Melbourne, Melbourne, Victoria, Australia.;Department of Haematology, Austin Health, Melbourne, Victoria, Australia.
[9]
Department of Neurology, Haukeland University Hospital, Bergen, Norway.
[10]
Department of Haematology, Haukeland University Hospital, Bergen, Norway.
[11]
Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
[12]
Department of Haematology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
[13]
Department of Haematology, 3rd Faculty of Medicine, Charles University in Prague, and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
[14]
Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia.;Central Clinical School, Monash University, Melbourne, Victoria, Australia.
[15]
University of Queensland, Brisbane, Queensland, Australia.;Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
[16]
Department of Neurology, The Alfred Hospital, Melbourne, Victoria, Australia.;Department of Neurology, Box Hill Hospital, Melbourne, Victoria, Australia.;Monash University, Melbourne, Victoria, Australia.
[17]
School of Medicine and Public Health, University Newcastle, Newcastle, New South Wales, Australia.;Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, New South Wales, Australia.
[18]
Department of Neurology, Antwerp University Hospital, Edegem, Belgium.;Translational Neurosciences Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
[19]
UOC Neurologia, Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy.
[20]
Dokuz Eylul University, Konak, Izmir, Turkey.
[21]
Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
[22]
Neurologic Clinic and Policlinic, Departments of Medicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.
[23]
Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania, Italy.;Multiple Sclerosis Center, University of Catania, Catania, Italy.
[24]
CHUM MS Center and Universite de Montreal, Montreal, Quebec, Canada.
[25]
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.;Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
[26]
Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
[27]
Flinders University, Adelaide, South Australia, Australia.
[28]
Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
[29]
Liverpool Hospital, Sydney, New South Wales, Australia.
[30]
Monash Medical Centre, Melbourne, Victoria, Australia.;Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
[31]
Garibaldi Hospital, Catania, Italy.
[32]
Department of Neurology, Centro Hospitalar Universitario de Sao Joao, Porto, Portugal.
[33]
Cliniques Universitaires Saint-Luc, Brussels, Belgium.;Université Catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium.
[34]
Academic MS Center Zuyderland, Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.;School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
[35]
Department of Neurology, University Hospital Ghent, Ghent, Belgium.
[36]
Department of Neurology, Hacettepe University Hospitals, Ankara, Turkey.
[37]
Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.
[38]
Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
[39]
Department of Neurology, Razi University Hospital, Manouba, Tunis, Tunisia.;Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
[40]
Hospital Universitario Donostia, San Sebastián, Spain.
[41]
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.;Royal Hobart Hospital, Hobart, Tasmania, Australia.
[42]
Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
[43]
Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
[44]
Westmead Hospital, Sydney, New South Wales, Australia.
[45]
Hospital de Galdakao-Usansolo, Galdakao, Spain.
[46]
University Hospital Reina Sofia, Cordoba, Spain.
[47]
Center of Neuroimmunology, Service of Neurology, Hospital Clinic de Barcelona, Barcelona, Spain.
[48]
Department of Medicine, Sultan Qaboos University Hospital, Al-Khodh, Oman.
[49]
Department of Neurology, Buffalo General Medical Center, Buffalo, New York.
[50]
Universidade Metropolitana de Santos, Santos, Brazil.
[51]
Groene Hart Ziekenhuis, Gouda, the Netherlands.
[52]
Perron Institute, University of Western Australia, Nedlands, Western Australia, Australia.;Institute of Immunology and Infectious Diseases, Sir Charles Gairdner Hospital, Murdoch University, Perth, Western Australia, Australia.
[53]
医学主题词
女(雌)性(Female);人类(Humans);成年人(Adult);多发性硬化(Multiple Sclerosis);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);造血干细胞移植(Hematopoietic Stem Cell Transplantation)
DOI
10.1001/jamaneurol.2023.1184
PMID
37437240
发布时间
2024-05-16
- 浏览0
JAMA neurology
JAMA neurology
2023年80卷7期
702-713页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
